Activation of the Src/p21(ras)/Erk pathway by progesterone receptor via cross-talk with estrogen receptor

EMBO Journal

Volumn 17, Issue 7, 1998, Pages 2008-2018

  Migliaccio, Antimo ^a   Piccolo, Domenico ^a   Castoria, Gabriella ^a   Domenico, Marina Di ^a   Bilancio, Antonio ^a   Lombardi, Maria ^a   Gong, Wenrong ^b   Beato, Miguel ^b   Auricchio, Ferdinando ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Estradiol receptor; Progesterone receptor; Progestins; Proliferation; Signal transduction

Indexed keywords

ANTIESTROGEN; ESTROGEN; ESTROGEN RECEPTOR; GESTAGEN; PROGESTERONE RECEPTOR; PROTEIN P21; RECEPTOR SUBTYPE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR; ESTRADIOL; GUANOSINE TRIPHOSPHATE; HORMONE ANTAGONIST; HRAS PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROGESTERONE RECEPTOR B; PROMEGESTONE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE C SRC; PROTEIN-TYROSINE KINASE C-SRC; TAMOXIFEN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BREAST TUMOR; CELL PROLIFERATION; CELL STRAIN COS1; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANIMAL; CARCINOMA; CELL CULTURE; DRUG ANTAGONISM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; POINT MUTATION; TRANSACTIVATION;

ANIMALIA;

ANIMALS; BREAST NEOPLASMS; CARCINOMA; COS CELLS; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; ESTRADIOL; GENE EXPRESSION REGULATION; GUANOSINE TRIPHOSPHATE; HORMONE ANTAGONISTS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; POINT MUTATION; PROMEGESTONE; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS P21(RAS); RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; TAMOXIFEN; TRANS-ACTIVATION (GENETICS); TUMOR CELLS, CULTURED;

EID: 0032036584     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.7.2008     Document Type: Article

References (66)

1. Akiyama,Y. and Ogavara,H. (1991) Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol., 201, 362-370.
2. Albanese,C., Johnson,J., Watanabe,G., Eklund,N., Vu,D., Amold,A. and Pestell,R.G. (1995) Transforming p21 ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem., 270, 23589-23597.
3. Altucci,L. et al. (1996) 17β-estradiol induces cyclin D1 gene transcription. p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene, 12, 2315-2324.
4. Aronica,S.M., Kraus,W.L. and Katzenellenbogen,B.S. (1994) Estrogen action via the cAMP signalling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc. Natl Acad. Sci. USA, 91, 8517-8521.
5. Auricchio,F., Di Domenico,M., Migliaccio,A., Castoria,G. and Bilancio,A. (1995) The role of estradiol receptor in the proliferative activity of vanadate on MCF-7 cells. Cell Growth Differ., 6, 105-113.
6. Beato,M., Herrlich,P., and Schütz,G. (1995) Steroid hormone receptors: many actors in search of a plot. Cell, 83, 851-857
7. Berthois,Y., Katzenellenbogen,J.A. and Katzenellenbogen,B.S. (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc. Natl Acad. Sci. USA, 83, 2496-2500.
8. Blackmore,P.F., Beebe,S.J., Danforth,D.R. and Alexander,N. (1990) Progesterone and 17 alpha-hydroxyprogesterone. Novel stimulators of calcium influx in human sperm. J. Biol. Chem., 265, 1376-1380.
9. Braunsberg,H., Coldham,N.G., Leake,R.E., Cowan,S.K. and Wong,W. (1987) Actions of progestogen on human breast cancer cells: mechanism of growth stimulation and inhibition. Eur. J. Cancer Clin. Oncol., 23, 563-571.
10. Bresciani,F. (1968) Topography of DNA synthesis in the mammary gland. An autoradiographic study. Cell Tissue Kinet., 1, 51-63.
11. Chalbos,D., Vignon,F., Keydar,I. and Rochefort,H. (1982) Estrogens stimulate cell proliferation and induce secretory proteins in a human breast cancer cell line (T47D). J. Clin. Endocrinol. Metab., 55, 276-283.
12. Clarke,C.L. and Sutherland,R.L. (1990) Progestin regulation of cellular proliferation. Endocr. Rev., 11, 266-302.
13. Davis,R.J. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem., 268, 14553-14556.
14. Deng,T.L. and Karin,M. (1994) c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature, 371, 171-175.
15. Derijard,B., Hibi,M., Wu,I.H., Barrett,T., Su,B., Deng,T.L., Karin,M. and Davis,R.J. (1994) Jnk1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell, 76, 1025-1037.
16. Di Domenico,M., Castoria,G., Bilancio,A., Migliaccio,A. and Auricchio,F. (1996) Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res., 56, 4516-4521.
17. Dickson,R. and Lippman,M.E. (1995) Growth factors in breast cancer. Endocr. Rev., 16, 559-589.
18. Endoh,H., Sasaki,H., Maruyama,K., Takeyama,K., Waga,I., Shimizu,T., Kato,S. and Kawashima,H. (1997) Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem. Biophys. Res. Commun., 235, 99-102.
19. Fantl,V., Stamp,G., Andrews,A., Rosewell,I. and Dickson,C. (1995) Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Dev., 9, 2364-2372.
20. Filmus,J., Robles,A.I., Shi,W., Wong,M.J., Colombo,L.L. and Conti,C.J. (1994) Induction of cyclin D1 overexpression by activated ras. Oncogene, 9, 3627-3633.
21. Gong,W., Chávez,S. and Beato,M. (1997) Point mutation in the ligand binding domain of the progesterone receptor generates a transdominant negative phenotype. Mol. Endocrinol., 11, 1476-1485.
22. Guy,C.T., Muthuswamy,S.K., Cardiff,R.D., Soriano,P. and Muller,W.J. (1994) Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev., 8, 23-32.
23. Hanke,J.H., Gardner,J.P., Dow,R.L., Changelian,P.S., Brissette,W.H., Weringer,E.J., Pollok,B.A. and Connelly,P.A. (1996) Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem., 271, 695-701.
24. Herber,B., Truss,M., Beato,M. and Müller,R. (1994) Inducible regulatory elements in the human cyclin D1 promoter. Oncogene, 9, 1295-1304.
25. Hissom,J.R., and Moore,M.R. (1987) Progestin effects on growth in the human breast cancer cell line T47D. Possible therapeutic implications. Biochem. Biophys. Res. Commun., 145, 706-711.
26. Humphreys,R.C., Lydon,J., O'Malley,B.W. and Rosen,J.M. (1997) Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol. Endocrinol., 11, 801-811.
27. Ignar-Trowbridge,D.M., NeIson,K.G., Bidwell,M.C., Curtis,S.W., Washburn,T.F., McLachlan,J.A. and Korach,K.S. (1992) Coupling of dual signalling pathways: epidermal growth factor action involves the estrogen receptor. Proc. Natl Acad. Sci. USA, 89, 4658-4662.
28. Kastner,P., Krust,A., Turcotte,B., Stropp,U., Tora,L., Gronemeyer,H. and Chambon,P. (1990) Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptors forms A and B. EMBO J., 9, 1603-1614.
29. Kato,S. et al. (1995) Activation of the estrogen receptor through phosphorylation by mitogen-activation protein kinase. Science, 270, 1491-1494.
30. Kerkhoff,E. and Rapp,U. (1997) Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-raf-1. Mol. Cell. Biol., 17, 2576-2586.
31. Kiss,R., Paridaens,R.J., Heuson,J.C. and Danguy,A.J. (1986) Effect of progesterone on cell proliferation in the MXT mouse hormone-sensitive mammary neoplasm. J. Natl Cancer Inst., 77, 173-178.
32. Korach,K.S. (1994) Insights from the study of animals lacking functional estrogen receptor. Science, 266, 1524-1527.
33. Kumar,V., Green,S., Stack,G., Berry,M., Jin,J.R. and Chambon,P. (1987) Functional domains of the human estrogen receptor. Cell, 51, 941-951.
34. MAPK pathway. J. Biol. Chem., 271, 20608-20616.
35. Lieberherr,M., Grosse,B., Duchambon,P. and Drucke,T. (1989) A functional cell surface type receptor is required for the early action of 1, 25-dihydroxyvitamin D3 on the phosphoinositide metabolism in rat enterocytes. J. Biol. Chem., 264, 20403-20406.
36. Lippman,M.E. and Dickson,R.B. (1989) Mechanism of growth control in normal and malignant breast epithelium. Recent Prog. Horm. Res., 45, 383-440
37. Longman,S.M. and Buehring,G.C. (1987) Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth. Cancer, 59, 281-287.
38. Lovec,H., Sewing,A., Lucibello,F.C., Müller,R. and Möröy,T. (1994) Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9, 323-326.
39. Lubahn,D.B., Moyer,J.S., Golding,T.S., Couse,J.F., Korach,K.S. and Smithies,O. (1993) Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl Acad. Sci. USA, 90, 11162-11166.
40. 1 checkpoint. Mol. Cell. Biol., 16, 6917-6925.
41. Lydon,J.P, De Mayo,F.J., Funk,C.R., Mani,S.K., Hughes,A.R., Montgomery,C.A.,Jr, Shyamala,G., Conneely,O.M. and O'Malley,B.W. (1995) Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev., 8, 2266-2278.
42. Manni,A., Badger,B., Wright,C., Ahmed,J.R. and Demers,L.M. (1987) Effect of progestins on growth of experimental breast cancer in culture: interaction with estradiol and prolactin and involvement of the polyamine pathway. Cancer Res., 47, 3066-3071.
43. Mendoza,C., Soler,A. and Tesarik,J. (1995) Nongenomic steroid action: independent targeting of a plasma membrane calcium channel and a tyrosine kinase. Biochem. Biophys. Res. Commun., 210, 518-523.
44. ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J., 15, 1292-1300.
45. Musgrove,E.A., Hamilton,J.A., Lee,C.S., Sweeney,K.J., Watts,C.K. and Sutherland,R.L. (1993) Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol., 13, 3577-3587.
46. Musgrove,E.A., Lee,C.S.L., Buckley,M.F. and Sutherland,R.L. (1994) Cyclin D1 induction in breast cancer cells shortens G1 and is sufficient for cells arrested in G1 to complete the cell cycle. Proc. Natl Acad. Sci. USA, 91, 8022-8026.
47. WAF1/CIP1 in human breast cancer. Int. J. Cancer, 63, 584-591
48. Muslin,A.J., Macnicol,A.M. and Williams,L.T. (1993) Raf-1 protein kinase is important for progesterone-induced Xenopus oocyte maturation and acts downstream of mos. Mol. Cell. Biol., 13, 4197-4202
49. Pappas,T.C., Gametchu,B. and Watson,C.S. (1995) Membrane estrogen receptor identified by multiple antibody labeling and impeded-ligand binding. FASEB J., 9, 404-410.
50. Pietras,R.J. et al. (1995) HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene, 10, 2435-2446.
51. Planas-Silva,M.D. and Weinberg,R.A. (1997) Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution Mol. Cell. Biol., 17, 4059-4069.
52. Power,R.F., Mani,S.K., Codina,J., Conneely,O.M. and O' Malley,B.W. (1991) Dopaminergic and ligand independent activation of steroid hormone receptors. Science, 254, 1636-1639.
53. Prall,O.W.J., Sarcevic,B., Musgrove,E.A., Watts,C.K.W. and Sutherland,R.L. (1997) Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2. J. Biol. Chem., 272, 10882-10894.
54. Russmann,C., Truss,M., Fix,A., Naumer,C., Herrmann,T., Schmitt,J., Stollhof,J., Beigang,R. and Beato,M. (1997) Crosslinking of progesterone receptor to DNA using tuneable nanosecond, picosecond and femtosecond UV laser pulses. Nucleic Acids Res., 25, 2478-2484.
55. Sagata,N., Oskarsson,M., Showalter,S.D. and Vandr,W. (1989) The product of the mos proto-oncogene as a candidate 'initiator' for oocyte maturation. Science, 245, 643-646.
56. Sartorius,C.A., Groshong,S.D., Miller,R.A., Powell,R.L., Tung,L., Takimoto,G.S. and Horwitz,K.B. (1994) New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP. Cancer Res., 54, 3868-3877.
57. Schlessinger,J. (1993) How receptor tyrosine kinase activate ras. Trends Biochem. Sci., 18, 273-275.
58. Schlessinger,J. and Ullrich,A. (1992) Growth factor signaling by receptor tyrosine kinases. Neuron, 9, 383-391.
59. Sicinski,P. et al. (1995) Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell, 82, 621-630.
60. Tora,L., Mullick,A., Metzger,D., Ponglikitmongkol,M., Park,I. and Chambon,P. (1989a) The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties. EMBO. J., 8, 1981-1986.
61. Tora,L., White,J., Brou,C., Tasset,D., Webster,N., Scheer,E. and Chambon,P. (1989b) The human estrogen receptor has two independent nonacid transcriptional activation functions. Cell, 59, 477-487.
62. Vignon,F., Bouton,M.M. and Rochefort,H. (1987) Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogens. Biochem. Biophys. Res. Commun., 146, 1502-1508.
63. Warner,M.R. (1978). Effect of perinatal oestrogen on the pretreatment required for mouse lobular formation in vitro. J. Endocrinol., 77, 1-10.
64. Walters,J.J., Campbell,J.S., Cunningham,M.J., Krebs,E.G. and Dorsa,D.M. (1997) Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signalling cascade and c-fos immediate early gene transcription. Endocrinology, 138, 4030-4032.
65. Weisz,A. and Bresciani,F. (1993) Estrogen regulation of proto-oncogenes 4 coding for nuclear proteins. Crit. Rev. Oncogen., 4, 361-388.
66. Zhang,Y., Bai,W., Allgood,V.E. and Weigel,N.L. (1994) Multiple signalling pathways activate the chicken progesterone receptor. Mol. Endocrinol., 8, 577-584.